HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
BTA9881
Description
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
No brand information found.
